Axogen AXGN
NASDAQ AXGN
$45.66 -3.27 (-6.68%)
At close: Aug 20, 2026 · 1:19 PM UTC

Axogen (AXGN) Net Equity Issued and Repurchased (2013 - 2026)

Axogen (AXGN) posted quarterly Net Equity Issued and Repurchased of $134.0 million for Q1 2026, up 13404300.0% quarter-over-quarter from $1000.0 in Q4 2018.

Axogen (AXGN) Net Equity Issued and Repurchased (2013 - 2026) Analysis & Trends

Axogen's Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at $134.0 million for Q1 2026.

  • In Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $134.0 million; the TTM figure through Jun 2026 stood at $134.0 million (up 13404300.0% YoY), while the FY2020 annual figure was $3.5 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased for Q1 2026 stood at $134.0 million, up from $1000.0 in the prior quarter.
  • The five-year high for Net Equity Issued and Repurchased was $134.0 million in Q1 2026, with the low at $134.0 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 198.95 Bn 193.35 Bn 7.27 Bn -
2 Stryker 128.10 Bn 124.63 Bn 4.50 Bn -
3 Medtronic 118.91 Bn 109.69 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 73.43 Bn 72.89 Bn 3.85 Bn -
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn -
6 Dexcom 34.52 Bn 32.58 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.94 Bn 31.83 Bn 2.18 Bn -
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn -
9 Steris 23.14 Bn 22.66 Bn 684.20 Mn -
10 Axogen 2.43 Bn 2.32 Bn 50.67 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 134.04 Mn
Mar 31, 2026 134.04 Mn
Dec 31, 2018 1,000.00
Dec 31, 2018 1,000.00
Dec 31, 2015 -2,349.00
Dec 31, 2015 -2,349.00
Sep 30, 2015 17.20 Mn
Sep 30, 2015 17.20 Mn
Jun 30, 2015 -1,399.00
Jun 30, 2015 -1,399.00
Mar 31, 2015 13.77 Mn
Mar 31, 2015 13.77 Mn
Dec 31, 2013 -6,457.00
Dec 31, 2013 -6,457.00